Fig. 4. FtLVS-GFP-Lux imaging after LPS vaccination

Slides:

Advertisements

Similar presentations

Preclinical evaluation of safety, efficacy, immunogenicity of a recombinant rBCG Pasteur B vaccine Group B4 March 16, 2011 Adane Miheret, Tewodros Tariku.

Advertisements

1 University of Texas San Antonio Update on F. tularensis attenuated vaccine strain construction and evaluation TVD Team 2/19/08 tech call.

Date of download: 9/18/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Effect of Genetic Background on the Response to Bacterial.

Targeting Improves MSC Treatment of Inflammatory Bowel Disease

Murine leptin deficiency alters Kupffer cell production of cytokines that regulate the innate immune system Zhiping Li, Huizhi Lin, Shiqi Yang, Anna.

S2 Fig. Phenotype of donor cells in the spleen and bone marrow of male mice. Splenocytes and bone marrow were isolated from male donor mice and stained.

Respiration 2012;83:74–80 - DOI: /

E-LIFE JOURNAL IF=8.5.

Fig. 1. Immune response anti-tetanus toxoid by enzyme-linked immunosorbent assay. Groups were immunized with two doses (3 weeks apart) and 2 weeks after.

Core Facility Operator

Fig. 2. Infection by lentivirus

Figure 1 Protective effects of acellular pertussis vaccines (A–F) in the respiratory infection model. Mice were challenged by exposure to an aerosol of.

Volume 17, Issue 9, Pages (September 2009)

Fig. 2. LUM015 fluorescently labels tumor cells in mouse models of STS and breast cancer. LUM015 fluorescently labels tumor cells in mouse models of STS.

Volume 43, Issue 5, Pages (November 2015)

Volume 22, Issue 1, Pages (January 2014)

Targeting Improves MSC Treatment of Inflammatory Bowel Disease

Volume 15, Issue 2, Pages (February 2014)

Volume 22, Issue 1, Pages e4 (July 2017)

Volume 15, Issue 5, Pages (May 2007)

Volume 17, Issue 5, Pages (May 2015)

Volume 24, Issue 2, Pages (February 2016)

Mycobacterium tuberculosis Inhibits Neutrophil Apoptosis, Leading to Delayed Activation of Naive CD4 T cells Robert Blomgran, Ludovic Desvignes, Volker.

Volume 17, Issue 8, Pages (August 2009)

Fig. 3 In situ vaccination with CpG and anti-OX40 is therapeutic in a spontaneous tumor model. In situ vaccination with CpG and anti-OX40 is therapeutic.

Volume 20, Issue 1, Pages (January 2012)

Volume 14, Issue 4, Pages (October 2013)

Survival of BALB/c mice after HK/Syd challenge.

Volume 16, Issue 12, Pages (December 2008)

Volume 18, Issue 3, Pages (March 2010)

by Kalpana Parvathaneni, and David W. Scott

Molecular Therapy - Nucleic Acids

Volume 18, Issue 9, Pages (September 2010)

Functional Characterization of Melanocyte Stem Cells in Hair Follicles

Volume 28, Issue 5, Pages (May 2008)

Volume 6, Issue 6, Pages (December 2009)

NKG2D-dependent NK cell function in CD11c-Rae1 mice

Bioluminescence imaging facilitates detection of tumor growth and metastasis in mouse orthotopic xenograft model. Bioluminescence imaging facilitates detection.

Volume 22, Issue 6, Pages (June 2014)

A B C p= ns 4T1BR5 GFP expression P10 P20 4T1BR5-Fluc-GFP Count

Resistance of CD141+ DCs to influenza virus in vivo in humanized mice.

Selection of a 4-1BB-endodomain–based anti-EGFRvIII CAR construct

Volume 37, Issue 6, Pages (December 2012)

Serial vaccination with 32Dp210-derived whole cell vaccines in non-tumor-bearing mice stimulates robust antileukemic cytolytic activity. Serial vaccination.

Volume 26, Issue 2, Pages (February 2018)

Weight and cardiopulmonary parameter changes in C57Bl/6 mice post IT-LPS or PBS. Weight changes were assessed in C57Bl/6 instilled via IT route with 50 µg.

Volume 4, Issue 3, Pages (September 2008)

Therapy model: CD34+CD33Del cells resist CD33-targeted immunotherapy.

Volume 21, Issue 5, Pages (May 2013)

Fig. 3 Intrarenal and RDLN lymphangiogenesis accompanied by lymphocyte expansion in the kidney, RDLN, and spleen. Intrarenal and RDLN lymphangiogenesis.

Figure 3 Downregulation of T-bet expression in brain-infiltrating MIF−/− CD4+ T cells Macrophage migration inhibitory factor (MIF)−/− and wild-type (Wt)

Vaccine MN confer protective innate and adaptive immunity.

MRP2 inhibition mitigates pulmonary burden and bacteremia following lung challenge with S. pneumoniae. MRP2 inhibition mitigates pulmonary burden and bacteremia.

Fig. 2 CD19 CAR T cells expressing tPSMA maintain function in vitro and in vivo. CD19 CAR T cells expressing tPSMA maintain function in vitro and in vivo.

Prime and boosts with PBK001 vaccine provided 100% protection with low bacterial burden in organs. Prime and boosts with PBK001 vaccine provided 100% protection.

Volume 19, Issue 6, Pages (May 2017)

Fig. 2. LUM015 fluorescently labels tumor cells in mouse models of STS and breast cancer. LUM015 fluorescently labels tumor cells in mouse models of STS.

Volume 20, Issue 6, Pages (June 2012)

Volume 20, Issue 4, Pages (April 2012)

Volume 23, Issue 6, Pages (June 2015)

Volume 43, Issue 5, Pages (November 2015)

Systemic reovirus treatment targets disseminated human myeloma in vivo

B- and T-cell activity induced by immunization.

Fig. 5 IL-5–mediated signaling is critical for the development of CD1dintCD5+ Breg precursor cells and IL-10+ Breg cells. IL-5–mediated signaling is critical.

In vivo efficacy of JAK inhibition in transformed Pax5+/− pro-B cells harboring Jak3V670A. In vivo efficacy of JAK inhibition in transformed Pax5+/− pro-B.

Volume 25, Issue 4, Pages (April 2017)

Engraftment of Bone Marrow–derived Stem Cells to the Lung in a Model of Acute Respiratory Infection by Pseudomonas aeruginosa Joanna Rejman, Carla Colombo,

GK1 enhances the secretion of proinflammatory cytokines resulting from cognate interactions between activated DCs and T cells. GK1 enhances the secretion.

Varying the MHC-I affinity, TCR affinity or antigen dose alters the phenotype of CD8 T cells ex vivo. Varying the MHC-I affinity, TCR affinity or antigen.

Fig. 1. Irradiated pneumococcal vaccine induced antibody titers

Presentation transcript:

Fig. 4. FtLVS-GFP-Lux imaging after LPS vaccination Fig. 4. FtLVS-GFP-Lux imaging after LPS vaccination. (A) Experimental plan to evaluate FtLVS-GFP-Lux imaging system. (B) Time-lapse imaging of splenocytes from non-vaccinated mouse and LPS vaccinated mouse. (C) Flow cytometry analysis of cells from organs of non-vaccinated mouse and LPS vaccinated mouse. (D) Bacterial burden on target organ after FtLVS-GFP-Lux challenge by LPS amount of vaccination. (E) Ex-vivo bioluminescence imaging of FtLVS-GFP-Lux infected mouse by LPS amount of vaccination. (F) Whole body bioluminescence imaging of FtLVS-GFP-Lux infected mouse with or without LPS vaccination. (G) Survival rate of infected mice with or without LPS vaccination. FtLVS, Francisella tularensis LVS; LPS, lipopolysaccharide; FACS, fluorescence-activated cell sorting; PBS, phosphate buffered saline; CFU, colony forming unit. Fig. 4. FtLVS-GFP-Lux imaging after LPS vaccination. (A) Experimental plan to evaluate FtLVS-GFP-Lux imaging system. (B) Time-lapse imaging of splenocytes from non-vaccinated mouse and LPS vaccinated mouse. (C) Flow cytometry analysis of cells from organs of non-vaccinated mouse… Clin Exp Vaccine Res. 2018 Jul;7(2):129-138. https://doi.org/10.7774/cevr.2018.7.2.129